Sinai Health System Selects Merge Healthcare for Vendor Neutral Archive, Radiology and Cardiology Imaging Platform
October 28 2013 - 7:00AM
Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of
clinical systems and innovations that seek to transform healthcare,
today announced that Sinai Health System, a Chicago-based
non-profit health system comprised of seven member organizations,
has selected Merge for its vendor-neutral archive (VNA), image
sharing and picture archiving communication systems (PACS), as well
as its cardiology information management and hemodynamics solution.
The partnership aims to improve workflow while reducing overall
costs for the entire health system.
"When we acquired Holy Cross Hospital, it became clear that we
needed to find an imaging management solution that enables us to
run on a single platform across our health system," said Peter
Ingram, vice president and CIO of Sinai Health System. "Combined
with hospital cost pressures and our population-based delivery care
model, we found Merge to not only be the most economical for us,
but also a partner who could provide the radiology and cardiology
imaging expertise that we needed within a VNA."
Sinai Health System selected Merge to replace several
end-of-life software systems as well as prepare for Meaningful Use
Stage 2 attestation. In order to create an integrated imaging
environment, the following technologies will be implemented,
including:
- iConnect® Enterprise Clinical Platform for interoperable image
viewing, sharing and archiving across the enterprise at the point
of care to enhance patient care and strengthen referral
networks.
- Merge PACS™ to read, review, archive and share images and
reports from a single location in real time, improving interactions
with radiologists and referring physicians.
- Merge Cardio™ for easy access and management to a patient's
integrated cardiovascular record for streamlined reporting and
distribution with an intuitive framework. In addition, Merge Cardio
automates the capture of charges to speed reimbursement.
- Merge Hemo™, ranked number one by KLAS, to automate cath lab
data collection, analysis and reporting processes for easy
integration into an electronic health record (EHR).
"At the end of the day, we want to provide a system that
radiologists, cardiologists and referring physicians are happy to
use, while helping support a more efficient workflow," continued
Ingram. "We foresee mobilizing clinical data outside the enterprise
in the near future and truly finding our place in an interoperable
workflow through implementation of Merge technology."
"We're thrilled to partner with Sinai Health System to deliver
an effective approach for achieving imaging integration across
their enterprise," said Justin Dearborn, CEO of Merge. "Our
commitment to providing the industry with innovative, long-term and
advanced imaging solutions is backed by Merge's recent Frost &
Sullivan 'Best in Interoperability' ranking. Further, our
partnership will enable Sinai Health System to successfully manage
current and upcoming industry trends and legislative drivers, such
as Meaningful Use Stage 2 attestation. We believe Sinai's forward
thinking approach to imaging integration will be replicated by
other large health systems seeking a more efficient methodology for
managing traditional disparate systems."
About Sinai Health System
Sinai Health System, a Chicago-based private, not-for-profit
organization, is comprised of seven member organizations: Mount
Sinai Hospital, Holy Cross Hospital, Sinai Children's Hospital,
Schwab Rehabilitation Hospital, Sinai Medical Group, Sinai
Community Institute and Sinai Urban Health Institute. The system
has over 800 physicians on its hospital medical staffs, 695
licensed beds, 100,000+ annual emergency department patient visits
and eight physician residency training programs.
About Merge
Merge is a leading provider of clinical systems and innovations
that seek to transform healthcare. Merge's enterprise and
cloud-based solutions for image intensive specialties provide
access to any image, anywhere, any time. Merge also provides
clinical trials software and other health data and analytics
solutions that engage consumers in their personal health. With
solutions that are used by providers and consumers and include more
than 25 years of innovation, Merge is helping to reduce costs and
improve the quality of healthcare worldwide. For more information,
visit merge.com.
Cautionary Notice Regarding Forward-Looking
Statements
The matters discussed in this news release may include
forward-looking statements, which could involve a number of risks
and uncertainties. When used in this press release, the words
"will," "believes," "intends," "anticipates," "expects" and similar
expressions are intended to identify forward-looking statements.
Actual results could differ materially from those expressed in, or
implied by, such forward-looking statements. Except as expressly
required by the federal securities laws, the Company undertakes no
obligation to update such factors or to publicly announce the
results of any of the forward-looking statements.
CONTACT: Media Contact:
Jennifer Jawor
Director, Corporate Marketing
312.565.6825
jennifer.jawor@merge.com
Mirage Energy (PK) (USOTC:MRGE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mirage Energy (PK) (USOTC:MRGE)
Historical Stock Chart
From Jul 2023 to Jul 2024